Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00423)
| DIG Name |
Maltitol
|
||||
|---|---|---|---|---|---|
| Synonyms |
maltitol; 585-88-6; D-Maltitol; 4-O-alpha-D-Glucopyranosyl-D-glucitol; Maltisorb; Malbit; Maltit; Amalti Syrup; Malti Mr; Amalty MR 100; UNII-D65DG142WK; MFCD00006600; D-4-O-alpha-D-Glucopyranosylglucitol; Amalty; MLS000069503; D65DG142WK; CHEBI:68428; Maltitol, 95%; (2S,3R,4R,5R)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol; Maltitol (D-Maltitol); SMR000058608; alpha-D-glucopyranosyl-(1->4)-D-glucitol; D-Glucitol, 4-O-a-D-glucopyranosyl-; (2S,3R,4R,5R)-4-(((2R,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,5,6-pentaol; Maltitol [BAN:NF]; Emportal; Floralac; Portolac; Oponaf; delta-Maltitol; HSDB 7971; Maltitol (NF); EINECS 209-567-0; BRN 0089983; Maltitol, >=98%; Opera_ID_636; Maltitol (6CI,7CI); D-Glucopyranosyl-D-glucitol; SCHEMBL15108; 4-o-alpha-d-Glucopyranosyl-; Manganese(IV)Oxide,Activated; 5-17-07-00145 (Beilstein Handbook Reference); MLS001148576; CHEMBL63558; DTXSID0044444; HMS2234B21; alpha-D-Glc-(1->4)-D-Glc-ol; HY-B2122; ZINC4262249; 4-O-alpha-Glucopyranosyl-D-sorbitol; alpha-D-Glcp-(1->4)-D-Glc-ol; s3950; alpha-D-glucosyl-(1->4)-D-glucitol; CCG-267963; SMP1_000186; CS-15369; D-Glucitol, 4-O-alpha-D-glucopyranosyl-; E965; 4-O-b-D-Galactopyranosyl-D-glucitol, 9CI; CS-0020280; D-Glucitol, 4--O-.alpha.-D-glucopyranosyl; delta-4-O-alpha-delta-Glucopyranosylglucitol; Glucitol, 4-O-alpha-D-glucopyranosyl-, D-; M0601; M0797; 4-O-alpha-delta-Glucopyranosyl-delta-glucitol; D04845; Q423882; SR-01000759231; Q-101038; SR-01000759231-4; Maltitol, European Pharmacopoeia (EP) Reference Standard; UNII-27F77DSJ5V component VQHSOMBJVWLPSR-WUJBLJFYSA-N; Maltitol, United States Pharmacopeia (USP) Reference Standard; Maltitol, Pharmaceutical Secondary Standard; Certified Reference Material; (2S,3R,4R,5R)-4-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)hexane-1,2,3,5,6-pentaol; (2S,3R,4R,5R)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyhexane-1,2,3,5,6-pentol; (2S,3R,4R,5R)-4-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexane-1,2,3,5,6-pentol; (2S,3R,4R,5R)-4-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}hexane-1,2,3,5,6-pentol
|
||||
| DIG Function |
Binding agent; Coating agent; Diluent; Flavoring agent
|
||||
| Formula |
C12H24O11
|
||||
| Canonical SMILES |
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O
|
||||
| InChI |
1S/C12H24O11/c13-1-4(16)7(18)11(5(17)2-14)23-12-10(21)9(20)8(19)6(3-15)22-12/h4-21H,1-3H2/t4-,5+,6+,7+,8+,9-,10+,11+,12+/m0/s1
|
||||
| InChIKey |
VQHSOMBJVWLPSR-WUJBLJFYSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 344.31 | Topological Polar Surface Area | 201 | |
| XlogP | -5.2 | Complexity | 343 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 8 | ||
| Hydrogen Bond Donor Count | 9 | Hydrogen Bond Acceptor Count | 11 | ||
Full List of Drug(s) Co-administrated with This DIG